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clinical score, while they were not detectable in the mice 
with low clinical score. Our results support the hypothesis 
that reinforcing the action of the GaBaergic network may 
represent a therapeutic alternative to limit the progression 
of the neuronal damage in Ms patients.
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Introduction
loss of neuronal function is an important pathological fea-
ture of multiple sclerosis (Ms), and there is evidence for the 
contribution of neuronal damage toward clinical disability 
(chard et al. 2002). analysis on postmortem control and 
Ms human brains has shown a reduction in the expression 
of a number of genes important in the neurotransmission by 
GaBaergic inhibitory neurons in the motor cortex (M1) of 
Ms patients (Dutta et al. 2006). GaBaergic interneurons 
may be grouped on the basis of the expression of different 
calcium binding proteins, such as parvalbumin (PV) and 
calretinin (cR) (DeFelipe 1997; Grateron et al. 2003; cot-
ter et al. 2002). PV and cR are members of the superfamily 
of EF-hand calcium binding proteins, which have a role in 
buffering the intracellular calcium (Baldellon et al. 1998). 
Defects in the expression of these calcium binding proteins 
have been implicated in a number of neurological patholo-
gies including Ms (Beers et al. 2001; Eyels et al. 2002). In 
particular, the data on postmortem Ms brains have indicated 
a reduction in the expression of the PV gene as well as the 
reduced extension of neurites in PV-expressing interneurons 
within normal appearing gray matter in Ms patients (Dutta 
et al. 2006). a comparative confocal microscopy analysis 
Abstract  In multiple sclerosis (Ms), inflammation leads 
to damage of central nervous system myelin and axons. 
Previous studies have postulated impaired GaBa trans-
mission in Ms, and recent postmortem analysis has shown 
that GaBaergic parvalbumin (PV)-positive interneurons 
are decreased in the primary motor cortex (M1) of patients 
with Ms. In this report, we present evidence for the loss 
of a specific population of GaBaergic interneurons in 
the experimental autoimmune encephalomyelitis mouse 
model of Ms. Using experimental autoimmune encephalo-
myelitis, we evaluated the distribution of both PV-positive 
interneurons and of the inhibitory presynaptic input in the 
M1 of experimental autoimmune encephalomyelitis and 
control mice. Our results demonstrate a specific decrease 
in the number of PV-positive interneurons in the M1 of 
mice with experimental autoimmune encephalomyelitis. 
We detected a significant reduction in the number of PV-
positive interneurons in the layers II and III of the M1 of 
diseased mice, while there was no difference in the num-
ber of calretinin (cR)-positive cells between animals with 
experimental autoimmune encephalomyelitis and control 
animals. Moreover, we observed a significant reduction in 
the inhibitory presynaptic input in the M1 of treated mice. 
these changes were specific for the mice with elevated 
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on the distribution of the immunoreactivity for different 
calcium binding proteins from normal and Ms postmor-
tem brains has shown a specific reduction in the number of 
PV-positive interneurons within layer II of the human Ms 
M1, while no changes could be detected in the number of 
cR-positive interneurons (clements et al. 2008).
Given the decrease in PV-positive interneurons in the 
brain of Ms patients, we tested if a similar phenotype could 
be induced in an animal model to study Ms. We looked at 
the effects of experimental autoimmune encephalomyeli-
tis (EaE) on the number and differentiation of PV-positive 
interneurons in the M1 of wild-type mice by comparing 
treated (EaE) and control animals, to establish whether we 
could reproduce the defect observed in the PV-positive cor-
tical population of Ms patients by using a well-established 
mouse model for EaE (Pluchino et al. 2003). We found that 
the number of PV-positive cells as well as the density of 
inhibitory presynaptic inputs on cortical pyramidal cells is 
markedly and specifically reduced in the M1 of EaE mice.
Materials and methods
Induction of EaE
EaE was induced according to published procedures 
(Furlan et al. 2009). Briefly, c57Bl/6 female mice 
Fig. 1  EaE clinical score. a group of treated mice (MOG, score 
2.5–3, n = 5) displays a pronounced clinical score compared with 
control mice injected with Freund’s adjuvant only (cFa, n = 10), 
while a second group of mice (MOG, score ≤1.5, n = 4) displays a 
lower clinical score. Data in the graph are expressed as mean ± sEM
Fig. 2  the brain of EaE animals shows infiltration by leukocytes. 
sections were immunostained for cD45 (red) and DaPI (blue) to 
identify inflammatory infiltrates of leukocytes. a low magnification of 
the motor cortex of a mouse with high clinical score. Arrows indicate 
some inflammatory lesions. Scale bar, 200 μm. b higher magnifica-
tion of the inflammatory lesions in the primary motor cortex shows in 
a. Scale bar, 20 μm. c lower magnification of the motor cortex of a 
mouse with low clinical score. Arrows indicate some inflammatory 
lesions. Scale bar, 200 μm. d higher magnification of inflammatory 
lesions in the primary motor cortex shows in c. Scale bar, 20 μm
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were injected at the same age (8 weeks, with a starting 
weight of 20–22 g). the mice were immunized with the 
same amount of immunogen by subcutaneous injection 
with 300 μl of MOG (35–55) peptide (200 μg, Multiple 
Peptide system) in incomplete Freund’s adjuvant con-
taining 8 mg/ml of Mycobacterium tuberculosis (strain 
h37Ra; Difco). Pertussis toxin (500 ng; from sigma) 
was injected intravenously on the day of the immuni-
zation and 2 days later. Body weight and clinical score 
were recorded daily. the following clinical scores were 
assigned: 0 = healthy; 1 = limp tail; 2 = ataxia and/or 
paresis of hind limbs; 4 = tetra paralysis; 5 = moribund 
or death. all procedures involving animals were per-
formed according to the guidelines of the animal Ethical 
committee of our Institute.
antibodies
antibodies used in this study were as follows: rabbit 
polyclonal antibodies against cR (chemicon Interna-
tional), PV (PV-28, swant), vesicular GaBa transporter 
(vGat, synaptic systems), and glial fibrillary acidic 
protein (GFaP, Dako cytomation); goat polyclonal anti-
body against PV (PVG-214, swant). the rat monoclonal 
Fig. 3  Increased number of 
astrocytes in the cortex of EaE 
mice. Z-stack projections of 
confocal images of layers II–III 
of the M1 of EaE mice immu-
nostained for GFaP (red) and 
DaPI (blue). Scale bar: 20 μm. 
the signal for GFaP is stronger 
in the motor cortex of EaE 
mice with pronounced clinical 
score (right). the signal for 
GFaP is very low in the motor 
cortex of control mice (left) and 
of EaE mice with low clinical 
score (center)
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antibody against cD45 was a kind gift of Gabriela con-
stantin (University of Verona). Primary antibodies were 
detected by alexa Fluor-conjugated secondary antibodies 
(Invitrogen) or biotinylated rabbit anti-rat and goat anti-
rabbit immunoglobulins (Vector laboratories).
Immunohistochemistry and immunofluorescence
Mice were sacrificed 30 days after immunization. Mice 
were fixed under deep anesthesia by transcardial perfu-
sion with 4 % paraformaldehyde in phosphate-buffered 
saline (PBs). the brain was removed and postfixed over-
night at 4 °c. For immunostaining, samples were washed 
with PBs, cryoprotected with sucrose in PBs, and frozen 
in optimal cutting temperature compound (VWR Inter-
national ltd.). 12-to 20-μm-thick sections were stained 
with cresyl violet or used for immunostaining. For immu-
nohistochemistry, sections were incubated with primary 
antibodies overnight at 4 °c. Primary antibodies were 
detected with the Vectastain Elite aBc Kit (Vector labo-
ratories). sections were viewed with a Zeiss axioplan2 
microscope with axiocam MRc5 digital camera (carl 
Zeiss MicroImaging). For immunofluorescence, pri-
mary antibodies were revealed by incubation for 1.5–2 h 
with alexa Fluor-conjugated secondary antibodies and 
4′,6-Diamidino-2-Phenylindole (DaPI, sigma-aldrich) 
Fig. 4  PV-positive a and  
cR-positive b GaBaergic 
interneurons in the M1 of 
control mice
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for nuclear staining. sections were viewed with a Zeiss 
axiovert 135 tV equipped with a QImaging Exi-Blue 
camera (carl Zeiss MicroImaging). confocal analysis 
was performed with a leica tcs sP2 (leica Microsys-
tems). Quantification with ImageJ software (NIh, 
Bethesda, MD) was performed on 6–7 sections from at 
least 3 different mice per genotype for each experimental 
condition.
apoptosis
terminal deoxynucleotidyl transferase dUtP nick end 
labeling (tUNEl) was performed using the DeadEnd col-
orimetric tUNEl system Kit (Promega). sections includ-
ing the M1 were processed following the manufacturer’s 
instructions and analyzed as described (Pennucci et al. 
2011). sections of the interdigit region of E13.5 wild-type 
mice (not shown) were used as positive controls (Fernan-
dez-teran et al. 2006).
Quantitative analysis
PV-positive and cR-positive cells were quantified in 12–15 
parasagittal sections from 3 mice per experimental condition. 
the density of PV-positive cells was evaluated from similar 
areas of the M1 using the ImageJ software. For quantifica-
tion of the presynaptic GaBaergic terminals, 24–26 fields 
from sections of the M1 of 3 mice per experimental condi-
tion were used. the fluorescent signal of PV and vGat was 
evaluated in equal areas from parasagittal sections includ-
ing comparable levels of layers II–III of the M1 of EaE and 
control mice. laser power and settings were the same for all 
samples within the same experiment. Images were analyzed 
with ImageJ. the area occupied by fluorescent signals above 
the background and the mean gray value were quantified in 
layers II–III of the M1. the mean gray value was calculated 
as the average intensity of fluorescence per unit area. Quan-
titative analysis of the colocalization of PV with vGat was 
performed using ImageJ.
Fig. 5  EaE causes the reduction in PV-positive interneurons in lay-
ers II–III of the M1. a PV staining of the M1 of EaE mice with high 
clinical score (right) and control mice (left). Scale bar, 200 μm. b 
Number of PV-positive neurons/mm2 in layers II–III of the M1 from 
EaE mice with elevated clinical score and control mice. c Number of 
PV-positive neurons/mm2 in layers V–VI of the M1 from EaE mice 
with pronounced clinical score and control mice. Graph bars are nor-
malized means ± sEM (n = 30 sections from 5 mice/experimental 
condition). ***P < 0.001
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Results
EaE causes a reduction in the number of PV-positive 
interneurons in the primary motor cortex
We examined para sagittal sections of primary M1 of EaE 
mice with elevated (2.5–3) and lower (≤1.5) clinical score 
(Fig. 1) by immunostaining with antibodies for cD45 to 
detect the presence of infiltrating leukocytes. We found 
several cD45-positive cells in the cortex of EaE mice with 
high clinical score. In mice with elevated clinical score 
(2.5–3), the signal for cD45 was clearly more extended 
with respect to the signal observed in mice with low score 
(Fig. 2). the immunohistological analysis showed that 
lesions in the cortex of the animals with elevated clini-
cal score were surrounded by more numerous clusters of 
cD45-positive leukocytes when compared to lesion found 
in less affected mice. We thus confirmed the presence of 
inflammatory lesions in the subpial and across the corti-
cal layers, as previously described (Mangiardi et al. 2011). 
We also immunostained brain sections to detect GFaP as a 
marker of astrocytes, which were increased in the cortex of 
EaE mice with elevated clinical score (2.5–3) with respect 
to control mice or EaE animals with lower scores (Fig. 3). 
these results confirm that gliosis is present in the cortex of 
EaE mice with elevated clinical score.
PV-positive GaBaergic interneurons are reduced in 
the striatum (Rossi et al. 2011) and in the hippocampal 
Fig. 6  EaE does not affect the number of cR-positive cells in the 
M1. a cR staining of the M1 of EaE and control mice. Scale bar, 
200 μm. b Number of cR-positive neurons/mm2 in layers II–III of 
the M1 of EaE and control mice. c Number of cR-positive neurons/
mm2 in layers V–VI of the M1 from EaE and control mice. Graph 
bars are normalized mean ± sEM (n = 24 sections from 5 mice/
experimental condition)
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ca1 area (Ziehn et al. 2010) of EaE mice. Moreover, it 
has been documented a significant reduction in the num-
ber of PV-positive interneurons within layer II of the M1 
of patients with Ms, while no concurrent change in the 
number of cR-positive neurons was observed (clements 
et al. 2008). We utilized immunohistochemistry to deter-
mine whether PV-positive interneurons were affected in 
the M1 of EaE mice. We sacrificed mice with pronounced 
(2.5–3) and low clinical scores (≤1.5) 30 days after immu-
nization, to look at PV- and cR-positive interneurons in 
the M1. cortical PV-positive cells (Fig. 4a) may include 
large basket and chandelier type morphologies, while cR-
positive cells (Fig. 4b) may include cajal–Retzius, double 
bouquet, and bipolar morphologies (amitai et al. 2002). In 
EaE mice with pronounced clinical score, the number of 
PV-positive interneurons in the M1 was reduced. a 30 % 
reduction was restricted to layers II–III, whereas no differ-
ences were detected in the layers V–VI (Fig. 5). In contrast 
to PV-positive cells, there was no difference in the number 
of cR-positive cells between EaE and control mice in the 
same cortical areas (Fig. 6). We performed the same analy-
sis in the M1 of EaE mice with low clinical score (≤1.5). 
Our data show no differences in the number of PV-positive 
cells in the M1 of these mice (Fig. 7).   
the loss of PV-positive cells observed in the M1 of EaE 
mice could be due to the neuronal death associated to the 
development of the disease (Mangiardi et al. 2011). We 
could confirm a significant increase in cell death in the M1 
of EaE mice with high clinical score, with respect to con-
trol mice, as detected by tUNEl staining (Fig. 8). these 
data suggest that the loss of the PV-positive interneurons 
in the M1 of EaE mice may be due to the death of these 
neurons.
the reduction in PV-positive interneurons in the primary 
motor cortex corresponds to a reduced inhibitory 
presynaptic input
Previous studies have postulated impaired GaBa trans-
mission in Ms and in EaE (Dutta et al. 2006; Rossi et al. 
2011). a significant reduction in the number of PV-posi-
tive striatal cells accompanied impaired GaBa signaling 
detected by electrophysiological, morphological, and bio-
chemical analysis (Rossi et al. 2011). Moreover, it has been 
Fig. 7  PV-positive cells are not affected in the cortex of EaE mice 
with low clinical score a. Scale bars, 200 μm. b Number of PV-
positive neurons/mm2 in layers II–III of the M1 from EaE mice with 
low clinical score and control mice. c Number of PV-positive neu-
rons/mm2 in layers V–VI of the M1 from EaE mice with low clini-
cal score and control mice. Graph bars are normalized mean ± sEM 
(n = 7–15 sections from 3 mice/experimental condition)
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demonstrated a reduction in the transcripts for genes related 
to the GaBaergic phenotype and a decrease in the density 
of inhibitory interneuron processes in the M1 samples from 
Ms patients (Dutta et al. 2006). to assess if the reduction in 
PV-positive interneurons observed in the present study was 
accompanied by an effect on the inhibitory input in mice 
with EaE, we analyzed markers of GaBa transmission by 
immunofluorescence confocal analysis. this analysis has 
shown that the PV-positive processes, as well as the vGat-
positive GaBaergic presynaptic terminals were reduced 
in the M1 (layers II–III) of EaE mice with high score for 
the disease (2.5–3) (Fig. 9a). We quantified the percentage 
of cortical area positive for either PV or vGat in sections 
from control (cFa, Freund’s adjuvant only) and EaE M1. 
the area occupied by either marker was strongly reduced 
in the EaE mice with high score with respect to control 
animals: the area occupied by PV was reduced by 52.2 %, 
while the area occupied by vGat was reduced by 56.5 % 
(Fig. 9b). Interestingly, quantification in the M1 showed 
that the extension of colocalization of PV with vGat at the 
inhibitory presynaptic sites was also decreased in the EaE 
mice compared to control animals (Fig. 10a,b). therefore, 
EaE induced a decrease in the presynaptic sites formed by 
PV-positive interneurons. On the other hand, the fraction 
Fig. 8  analysis of cell death 
in the M1. a,b tUNEl staining 
of the motor cortex from EaE 
mice with high clinical score (a 
and b, left panels) and control 
(b right panel) mice. Scale bars, 
100 μm. c Number of tUNEl-
positive cells/mm2 in layers 
II–III of the M1 from EaE mice 
with high clinical score and 
control mice. Graph bars are 
mean ± sEM (n = 15 sections 
from 3 mice/experimental con-
dition). ***P < 0.001
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Fig. 9  the inhibitory presynap-
tic input is reduced in the M1 of 
EaE mice. a confocal images 
of layers II–III of the M1 immu-
nostained for the presynaptic 
marker vGat (red), PV (green) 
and DaPI (blue). Scale bars, 
50 μm. b Reduction of the 
signal for both PV and vGat in 
layers II–III of the M1 of EaE 
and control mice. Graph bars 
are normalized mean ± sEM 
(n = 26 cortical fields from 3 
mice/experimental condition). 
**P < 0.005
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of PV-positive structures positive for vGat, as well as the 
fraction of vGat-positive structures positive for PV were 
similar between EaE and control mice (Fig. 10c), suggest-
ing that the input by other types of GaBaergic interneu-
rons may also be affected in the EaE mice. Overall, our 
data indicate that the reduction in the number of PV-pos-
itive interneurons in the M1 of EaE mice corresponds to 
a reduction in the inhibitory presynaptic input on principal 
cortical neurons. 
Discussion
In this study, we have addressed the effects of EaE on the 
cortical GaBaergic inhibitory network. Based on pre-
vious findings in Ms patients (clements et al. 2008), we 
have considered two classes of interneurons present in the 
M1: the PV-positive and the cR-positive cells. consistently 
with the findings in the human Ms patients, we observed a 
specific negative effect of EaE on the PV-positive interneu-
rons that appear to be more sensitive to the disease when 
compared to the cR-positive inhibitory interneurons.
the calcium binding proteins PV and cR are expressed 
in distinct GaBaergic interneuron populations, and they 
are known to buffer calcium concentrations to protect neu-
rons from rises in intracellular calcium (Baldellon et al. 
1998). Perturbations in calcium binding proteins have been 
suggested to accompany a number of pathological condi-
tions including Ms (Beers et al. 2001; Eyels et al. 2002). 
these two interneuron populations are characterized by 
different developmental, electrophysiological, and struc-
tural parameters (amitai et al. 2002; Grateron et al. 2003; 
DeFelipe 1997). the current study reveals a significant loss 
of PV-positive interneurons in the M1 of EaE mice when 
compared to controls. this change was not associated to 
any alteration in the number of cR-positive interneurons, 
suggesting a specific sensitivity of the PV-positive cells to 
the disease. the reduction in PV-positive interneurons was 
restricted to cortical layers II–III, whereas no differences 
were detected in layers V–VI. Furthermore, these changes 
were evident only when high clinical scores were reached, 
since no differences in the number of PV-positive interneu-
rons could be observed in the M1 of mice with low clinical 
score. these data suggest that the loss of cortical PV-posi-
tive interneurons may represent a relatively late hallmark of 
the disease.
Previous studies have indicated that the presynaptic axon 
terminals of PV-positive cells innervate either the axon 
initial segment or the cell body and proximal dendrite of 
pyramidal neurons in layers III of the frontal cortex (lewis 
et al. 2012). We have quantified the signals for PV and for 
the GaBaergic presynaptic marker vGat (tafoya et al. 
2006; centonze et al. 2008) to assess if the observed reduc-
tion in PV-positive cells corresponds to a lower inhibitory 
input in the cortex. the analysis showed that the reduction 
in the GaBaergic presynaptic terminals in the M1 of EaE 
mice was evident only in animals with a high score for the 
disease.
Fig. 10  colocalization of PV with GaBaergic presynaptic termi-
nals in the M1 of EaE and control mice. a confocal images from 
layers II–III of the M1 immunostained for the presynaptic marker 
vGat (red), PV (green), and DaPI (blue). Scale bar, 20 μm. b area 
of colocalization of PV with vGat in the cortex of EaE and con-
trol mice. c Percentage of the area of colocalization of vGat and PV 
with respect to either the total area positive for vGat (light gray) or 
the total area positive for PV (dark gray). Graph bars in b and c are 
mean ± sEM (n = 9 from 3 mice/experimental condition)
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In conclusion, our data demonstrate that the inhibitory 
circuitry of the M1 is affected by EaE and suggest that 
the population of PV-positive interneurons is specifically 
vulnerable to the pathological insult that is subsequent to 
EaE progression. the reason for this specific vulnerabil-
ity is unknown. since the effects on PV-positive neurons 
were only detectable in mice with elevated clinical score, 
the results suggest that loss of these neurons is a hallmark 
of the advanced stages of the disease. Finally, together 
with previous studies implicating a GaBaergic defect in 
other areas of the brain during the development of the dis-
ease (Rossi et al. 2011; Ziehn et al. 2010), our results sup-
port the hypothesis that the reinforcement of the signaling 
linked to the action of GaBaergic interneurons may be a 
valid therapeutic alternative to control the progression of 
the neuronal damage in Ms patients.
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